Read more
This volume will describe both growth-inhibitory and mucin-depleting effects of bromelain and N-acetylcysteine, on their own or in combination, in cancer. It will coherently review the pathophysiological aspects of the mucin glycoproteins in malignancies and provide an updated account of the status of bromelain and N-acetylcysteine in cancer therapy.
The volume will develop the idea of using these two drugs as a combination formulation for mucin-depleting effects.
List of contents
1 Peritoneal dissemination of gastrointestinal tumors.- 2 Mucins and tumor biology.- 3 Bromelain.- 4N-acetylcysteine.- 5 A novel approach to peritoneal dissemination ofmucin-expressing malignancies of gastrointestinal origin.- Summary and futurepotential directions.
About the author
Afshin
Amini is MD, PhD at Department of Surgery, Research and Education Center, St.
George Hospital, The University of New South Wales, Sydney, Australia.
David L. Morris is Professor, The University of New South Wales,
Head, Department of Surgery, St. George Hospital, NSW, Australia
Samar Masoumi-Moghaddam is MD, PhD at Department of Surgery,
Research and Education Center, St. George Hospital, The University of New South
Wales, Sydney, Australia.
Summary
This volume will describe both growth-inhibitory and mucin-depleting effects of bromelain and N-acetylcysteine, on their own or in combination, in cancer. It will coherently review the pathophysiological aspects of the mucin glycoproteins in malignancies and provide an updated account of the status of bromelain and N-acetylcysteine in cancer therapy.
The volume will develop the idea of using these two drugs as a combination formulation for mucin-depleting effects.
